Overview |
bs-9618R |
DRIP1 Polyclonal Antibody |
WB, IHC-P, IF(IHC-P) |
Human, Mouse, Rat |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human DRIP1/C14orf28 |
31-130/310 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
122525 |
CN028_HUMAN; Dopamine receptor interacting protein 1; Dopamine receptor-interacting protein 1; DRIP 1; DRIP1; Uncharacterized protein C14orf28; C14orf28. |
1.C14ORF28, GNB2L1, MLLT3, DRD2 and DARPP-32 are important in the pathogenesis of schizophrenia and bipolar disorder; 2. these two disorders share common disease-related mechanisms linked to dopamine signalling; 3. the expression of these genes is closely correlated; and 4. DRD2 provides the initial trigger in the pathogenesis of these disorders. |
Application Dilution |
WB |
1:300-5000 |
IHC-P |
1:200-400 |
IF(IHC-P) |
1:50-200 |